Biocure appoints Bjorn Cochlovius as president
Dr. Cochlovius is a Molecular Biologist and Associate Professor for Immunology at Heidelberg University, Heidelberg, Germany.
Dr. Cochlovius' academic career focused on Tumor Immunology and Recombinant Antibodies.
Dr. Cochlovius has been Guest Scientist at Zelig Eshhar's lab at the Weizmann Institute, a pioneer of CAR-T cell technology.
He then joins the industry and held various leadership positions in biotech (e.g. Affitech, Oslo) and big pharma (amongst others at Roche, Basel; Abbvie, Singapore) in R&D, BD&L and strategic positions. ■